Researchers apply AI to unique database of healthcare workers' blood samples to determine best antigen to protect against multiple pathogens and variants

Tel Aviv-based startup that uses AI to build digital models of the human immune system and diseases inks multi-million-dollar with French drugmaker

Biond Biologics hopes its therapy, which activates 3 separate immune pathways, will prove to be 'strong and sustained anti-tumor response,' says CEO; human trials to start mid-2021